<DOC>
	<DOCNO>NCT00742573</DOCNO>
	<brief_summary>This study determine whether combination treatment driven patient choice well standardized medication treatment retain improve Hispanic patient major depressive disorder .</brief_summary>
	<brief_title>Incorporating Patient Treatment Choice Improve Treatment Retention Depressed Hispanics</brief_title>
	<detailed_description>Retention Hispanics treatment major depressive disorder ( MDD ) continue major public health problem . Hispanics drop treatment two three time frequently non-Hispanic white , despite scarcity treatment alternative Hispanics low rate re-entry mental health care system . Consistent goal Healthy People 2010 President 's New Freedom Commission Mental Health , goal study test efficacy research set novel intervention improve retention response . This efficacy assessment would serve reference point development future effectiveness trial community setting . Our intervention found grow evidence depress Hispanics seek help mental health problem , prefer receive psychotherapy combine treatment form weekly in-person clinic visit . However , socioeconomic barrier , low-paying job irregular hour , lack child care , limited time availability , often reduce treatment retention result dropout rate three time non-Hispanic white . Based emerge literature promise pilot data , propose study efficacy depress Hispanics intervention would allow patient choice follow option : 1 ) Medication alone , follow Texas Medication Algorithm Depression ( TMA ) ; 2 ) Brief Interpersonal Psychotherapy ( IPT-B ) alone , optional telephone session ; 3 ) Combined medication plus IPT-B . This intervention would allow switch treatment modality ( e.g. , IPT-B alone combine treatment ) point study period . We hypothesize permit patient choice among evidence-based treatment , flexibility sequential use treatment , novel treatment delivery system , intervention substantially increase retention Hispanics MDD treatment . Furthermore , examine mediator moderator retention , include stigma insurance coverage . We propose test intervention depress Hispanics seek outpatient psychiatric treatment use randomize trial TMA control group . Both group access medication use TMA one group offer IPT_B . . We test association treatment , retention , response course acute MDD care ( 12 week ) , also obtain preliminary outcome data 9 month treatment ( i.e. , total 12 month ) . Our pilot data enable u estimate sample size acute phase , additional follow-up period allow u examine effect choice longer-term course MDD care .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Hispanic male female DSMIV criterion nonpsychotic major depressive disorder ( MDD ) least moderate severity ( HAMD17 &gt; 18 ) 18 79 Patients stable dosage Benzodiazepines treat anxiety disorder At risk attempt suicide Unstable medical illness History bipolar disorder , schizophrenia , psychotic disorder Pregnant lactating Alcohol substance use disorder require acute detoxification</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Mood Disorders</keyword>
	<keyword>Hispanic</keyword>
</DOC>